People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Healthtech, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NoHo Dental , Inc. | — | Healthtech | Series D+ | $268.6M | $741.2M | 2024 |
| Diverge Health, Inc. | — | Healthtech | Series C | $68.2M | $407.5M | 2024 |
| Asset Blue Pharmacy Services, Inc. | — | Biotech / Pharma | Series B | $48.0M | $104.6M | 2022 |
| FirstHand Health, Inc. | — | Healthtech | Series B | $42.9M | $302.6M | 2021 |
| Synapse Health, Inc. | — | Healthtech | Series B | $40.0M | $220.1M | 2022 |
Benjamin Robbins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Benjamin Robbins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Hayek | 3 | 13 |
| Cory Roberts | 3 | 9 |
| Lee Fixel | 1 | 20 |
| Ryan Johnson | 1 | 9 |
| Lynne Chou O'Keefe | 1 | 7 |
| Annie Kadavy | 1 | 5 |
| Binoy Bhansali | 1 | 4 |
| Larson Douglas Hudson | 1 | 3 |
| Jed Cairo | 1 | 3 |
| Patrick Chun | 1 | 3 |
| Brian Bouma | 1 | 2 |
| Samir Malik | 1 | 2 |
| John Lyman | 1 | 2 |
| Roshni Chandwani | 1 | 2 |
| Tony Kilgore | 1 | 1 |
| Anthony Kilgore | 1 | 1 |
| Ananth Lalithakumar | 1 | 1 |
| Mark Thierer | 1 | 1 |
| Jeffrey Park | 1 | 1 |
| Jonathon Thierer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.